Dapagliflozin Lowers HbA1c, Systolic Blood Pressure and Serum Uric Acid in Patients With Type 2 Diabetes and Hypertension, Regardless of Class of Concomitant Antihypertensive Therapy

被引：0
|
作者：
Weber, Michael A.
Mansfield, Traci A.
Iqbal, Nayyar
Parikh, Shamik J.
Ptaszynska, Agata
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Diabetes (Type II); Antihypertensive agents; Blood pressure; Hypertension; Glucose;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13640
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes
    E. S. Kilpatrick
    A. S. Rigby
    S. L. Atkin
    Diabetologia, 2008, 51 : 365 - 371
  • [22] Association of Mean and Variability of HbA1c with Heart Failure in Patients with Type 2 Diabetes
    Lin, You-Ting
    Huang, Wei-Lun
    Wu, Hung-Pin
    Chang, Man-Ping
    Chen, Ching-Chu
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (07)
  • [23] Effect of tight control of HbA1c and blood pressure on cardiovascular diseases in type 2 diabetes: An observational study from the Swedish National Diabetes Register (NDR)
    Cederholm, Jan
    Zethelius, Bjorn
    Nilsson, Peter M.
    Eeg-Olofsson, Katarina
    Eliasson, Bjorn
    Gudbjornsdottir, Soffia
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 86 (01) : 74 - 81
  • [24] Aquatic training improves HbA1c, blood pressure and functional outcomes of patients with type 2 diabetes: A systematic review with meta-analysis
    Leonel, Larissa dos Santos
    de Brum, Guilherme
    Alberton, Cristine Lima
    Delevatti, Rodrigo Sudatti
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [25] Impact of changes in HbA1c, lipids and blood pressure on long-term outcomes in type 2 diabetes patients:: An analysis using the CORE Diabetes Model
    Palmer, AJ
    Roze, S
    Valentine, WJ
    Minshall, ME
    Hayes, C
    Oglesby, A
    Spinas, GA
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 : S53 - S58
  • [26] Model-based characterization of the relationship between dapagliflozin systemic exposure and HbA1c response in patients with type 1 diabetes mellitus
    Parkinson, Joanna
    Tang, Weifeng
    Astrand, Magnus
    Melin, Johanna
    Ekholm, Ella
    Hamren, Bengt
    Boulton, David W.
    DIABETES OBESITY & METABOLISM, 2019, 21 (06): : 1381 - 1387
  • [27] Influence of HbA1c on short-term blood pressure variability in type 2 diabetic patients with diabetic nephropathy
    Fang LIU
    Min WU
    Yan-huan FENG
    Hui ZHONG
    Tian-lei CUI
    You-qun HUANG
    Ya-ping LIANG
    Yong-shu DIAO
    Li ZANG
    Ling LI
    Jing ZANG
    Hong-yu QIU
    Song-min HUANG
    Ping FU
    Journal of Zhejiang University-Science B(Biomedicine & Biotechnology), 2013, (11) : 1033 - 1040
  • [28] Influence of HbA1c on short-term blood pressure variability in type 2 diabetic patients with diabetic nephropathy
    Fang Liu
    Min Wu
    Yan-huan Feng
    Hui Zhong
    Tian-lei Cui
    You-qun Huang
    Ya-ping Liang
    Yong-shu Diao
    Li Zang
    Ling Li
    Jing Zang
    Hong-yu Qiu
    Song-min Huang
    Ping Fu
    Journal of Zhejiang University SCIENCE B, 2013, 14 : 1033 - 1040
  • [29] Visit-to-visit HbA1c variability and systolic blood pressure (SBP) variability are significantly and additively associated with mortality in individuals with type 1 diabetes: An observational study
    Wightman, Stuart S.
    Sainsbury, Christopher A. R.
    Jones, Gregory C.
    DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 1014 - 1017
  • [30] THE REAPPRAISAL OF THE ASSOCIATION OF GLYCOSYLATED HEMOGLOBIN A1C (HBA1C) AND BLOOD-PRESSURE - A HYPERTENSION AND DIABETES STUDY IN A TAIWAN RURAL AREA
    CHU, NF
    LEE, MMS
    WANG, DJ
    CHEN, LM
    SHIEH, SM
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (02) : 173 - 179
12345